Read more
This updated third edition offers a comprehensive and comparative analysis of the technologies fueling the major life-enhancing improvements in healthcare globally, including the ingredients for their successful development and commercialisation. Based on solid research, it focuses on practical business strategy issues for executives and students.
List of contents
1. Product suppliers in the health care value chain Lawton Robert Burns; 2. The pharmaceutical sector Richard T. Evans and Scott Hinds; 3. The biotechnology sector - therapeutics Cary G. Pfeffer; 4. New venture creation in biotechnology Jason Rhodes and Lawton Robert Burns; 5. The medical device sector Kurt H. Kruger and Max A. Kruger; 6. Financing medtech innovation Justin Klein; 7. The healthcare information technology sector Adam C. Powell and John Glaser.
About the author
Lawton Robert Burns, Ph.D., is the James Joo-Jin Kim Professor Health Care Management, Director of the Wharton Center for Health Management and Economics, and the Co-Director of the Vagelos Program in Life Sciences and Management at the Wharton School, University of Pennsylvania. He has conducted research on the tech sectors in healthcare for the past two decades, covering pharmaceuticals, biotechnology, medical devices, medical-surgical supplies and information technology. He teaches executives and is a regular expert witness in litigation involving these sectors.
Summary
This updated third edition offers a comprehensive and comparative analysis of the technologies fueling the major life-enhancing improvements in healthcare globally, including the ingredients for their successful development and commercialisation. Based on solid research, it focuses on practical business strategy issues for executives and students.
Additional text
'This is an important and opportune time to study and understand the medical technology sector of the healthcare market. This book does an excellent job of simplifying this complicated subject into its unique elements, analyzing each in a clear, direct style that illuminates the key issues facing this rapidly changing industry. The discussion of the sources of, impediments to and changing attitude toward device innovation and regulation are particularly welcome. I recommend this astute analysis to healthcare executives, policymakers, investors, innovators and anyone else who wants to understand the critical importance and future direction of the medical technology industry and its innovation for patients around the world.' Michael Mussallem, Chairman and CEO, Edwards Life Sciences
